ciprofloxacin has been researched along with Haemophilus Infections in 43 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Haemophilus Infections: Infections with bacteria of the genus HAEMOPHILUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-nine adult patients with cystic fibrosis who had chronic bronchopulmonary infection were randomly assigned to receive 750 or 1,000 mg of oral ciprofloxacin every 12 hours for two weeks." | 9.06 | Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. ( Chartrand, SA; Hilman, BC; Marks, MI; Shalit, I; Stutman, HR, 1987) |
| "Eighty hospital patients with acute purulent exacerbations of chronic bronchitis associated with Haemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis or Pseudomonas aeruginosa were treated with ciprofloxacin." | 7.67 | Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. ( Baur, C; Davies, BI; Maesen, FP, 1986) |
| "The use of ciprofloxacin for the treatment of pulmonary infection in cystic fibrosis patients was investigated." | 7.67 | The use of ciprofloxacin in the treatment of patients with cystic fibrosis. ( Bakker, W; Mattie, H; van den Broek, PJ; van Gulpen, C, 1987) |
| "An experimental murine model of bacteraemic Haemophilus influenzae pneumonia was used to evaluate the therapeutic efficacy of ciprofloxacin, as compared with ampicillin and chloramphenicol." | 7.67 | Comparative efficacies of ciprofloxacin, ampicillin and chloramphenicol in treatment of experimental Haemophilus influenzae pneumonia. ( Borner, K; Kemmerich, B; Pennington, JE, 1987) |
| "Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days." | 7.67 | Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin. ( Hoogkamp-Korstanje, JA; Klein, SJ, 1987) |
| "Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections." | 5.29 | Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. ( Baquero, F; Campos, J; Cantón, R; Escobar, H; García, C; Georgiou, M; Gómez-Lus, R; Román, F, 1996) |
| "Twenty-nine adult patients with cystic fibrosis who had chronic bronchopulmonary infection were randomly assigned to receive 750 or 1,000 mg of oral ciprofloxacin every 12 hours for two weeks." | 5.06 | Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. ( Chartrand, SA; Hilman, BC; Marks, MI; Shalit, I; Stutman, HR, 1987) |
| "Eighty hospital patients with acute purulent exacerbations of chronic bronchitis associated with Haemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis or Pseudomonas aeruginosa were treated with ciprofloxacin." | 3.67 | Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. ( Baur, C; Davies, BI; Maesen, FP, 1986) |
| "The use of ciprofloxacin for the treatment of pulmonary infection in cystic fibrosis patients was investigated." | 3.67 | The use of ciprofloxacin in the treatment of patients with cystic fibrosis. ( Bakker, W; Mattie, H; van den Broek, PJ; van Gulpen, C, 1987) |
| "An experimental murine model of bacteraemic Haemophilus influenzae pneumonia was used to evaluate the therapeutic efficacy of ciprofloxacin, as compared with ampicillin and chloramphenicol." | 3.67 | Comparative efficacies of ciprofloxacin, ampicillin and chloramphenicol in treatment of experimental Haemophilus influenzae pneumonia. ( Borner, K; Kemmerich, B; Pennington, JE, 1987) |
| "Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days." | 3.67 | Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin. ( Hoogkamp-Korstanje, JA; Klein, SJ, 1987) |
| "Ciprofloxacin therapy was well tolerated; ceftriaxone therapy was discontinued in two patients (8%) due to adverse reactions (intramuscular pain and drug fever)." | 2.67 | A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. ( Gruninger, RP; Guay, DR; Hirata-Dulas, CA; Peterson, PK; Stein, DJ, 1991) |
| "Otitis media is the most common reason U." | 1.43 | Treatment of otitis media by transtympanic delivery of antibiotics. ( Guo, S; Kohane, DS; Lin, LY; Okonkwo, OS; Pelton, SI; Rosowski, JJ; Sabharwal, V; Shlykova, N; Tong, R; Wang, W; Yang, R, 2016) |
| "A 73-year-old woman with liver cirrhosis who developed H." | 1.30 | Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis. ( Chang, SC; Chen, YC; Fang, CT; Hsieh, WC; Hsueh, PR; Hung, CC; Luh, KT, 1997) |
| "An unusual case of discitis and vertebral osteomyelitis due to Haemophilus aphrophilus is described." | 1.29 | Haemophilus aphrophilus discitis and vertebral osteomyelitis. ( George, RC; Johnson, AP; Keene, GS; O'Driscoll, JC; Palepou, MF; Weinbren, MJ, 1995) |
| "Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections." | 1.29 | Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. ( Baquero, F; Campos, J; Cantón, R; Escobar, H; García, C; Georgiou, M; Gómez-Lus, R; Román, F, 1996) |
| "Ciprofloxacin and ofloxacin were the most active agents, (MIC90 0." | 1.28 | In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients. ( Lingaas, E; Teigen, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (16.28) | 18.7374 |
| 1990's | 15 (34.88) | 18.2507 |
| 2000's | 12 (27.91) | 29.6817 |
| 2010's | 7 (16.28) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Vázquez, M | 2 |
| Román, F | 3 |
| García-Cobos, S | 1 |
| Campos, J | 3 |
| Su, PY | 1 |
| Cheng, WH | 1 |
| Ho, CH | 1 |
| Tabuenca Del Barrio, L | 1 |
| Mozo Cuadrado, M | 1 |
| Compains Silva, E | 1 |
| Aliseda Pérez De Madrid, D | 1 |
| Heras Mulero, H | 1 |
| Aguirre-Quiñonero, A | 1 |
| Canut, A | 1 |
| Cavaliere, R | 1 |
| Ball, JL | 1 |
| Turnbull, L | 1 |
| Whitchurch, CB | 1 |
| Puig, C | 1 |
| Tirado-Vélez, JM | 1 |
| Calatayud, L | 1 |
| Tubau, F | 1 |
| Garmendia, J | 1 |
| Ardanuy, C | 1 |
| Marti, S | 1 |
| de la Campa, AG | 1 |
| Liñares, J | 1 |
| Cardines, R | 1 |
| Daprai, L | 1 |
| Giufrè, M | 1 |
| Torresani, E | 1 |
| Garlaschi, ML | 1 |
| Cerquetti, M | 1 |
| Risse, J | 1 |
| Settembre, N | 1 |
| Mandry, D | 1 |
| Benayad, H | 1 |
| Lemarié, C | 1 |
| Alauzet, C | 1 |
| Zuily, S | 1 |
| Bertaux, A | 1 |
| Malikov, S | 1 |
| Claudon, M | 1 |
| Wahl, D | 1 |
| Fuursted, K | 1 |
| Hartmeyer, GN | 1 |
| Stegger, M | 1 |
| Andersen, PS | 1 |
| Justesen, US | 1 |
| Yang, R | 1 |
| Sabharwal, V | 1 |
| Okonkwo, OS | 1 |
| Shlykova, N | 1 |
| Tong, R | 1 |
| Lin, LY | 1 |
| Wang, W | 1 |
| Guo, S | 1 |
| Rosowski, JJ | 1 |
| Pelton, SI | 1 |
| Kohane, DS | 1 |
| Nakamura, S | 1 |
| Yanagihara, K | 1 |
| Araki, N | 1 |
| Morinaga, Y | 1 |
| Izumikawa, K | 1 |
| Seki, M | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Kamihira, S | 1 |
| Kohno, S | 1 |
| Miklaszewska, M | 1 |
| Klepacka, J | 1 |
| Drozdz, D | 1 |
| Zachwieja, K | 1 |
| Pietrzyk, JA | 1 |
| Kadłubowski, M | 1 |
| Hryniewicz, W | 1 |
| Bezwada, HP | 1 |
| Nazarian, DG | 1 |
| Booth, RE | 1 |
| Breck, RW | 1 |
| Vitkauskiene, A | 1 |
| Sakalauskas, R | 1 |
| Dudzevicius, V | 1 |
| Aracil, B | 1 |
| Cantón, R | 2 |
| Mai, T | 1 |
| Mouly, S | 1 |
| Jarrin, I | 1 |
| Mahé, I | 1 |
| Sellier, P | 1 |
| Bergmann, JF | 1 |
| Yang, KS | 1 |
| Chen, YF | 1 |
| Hwang, YS | 1 |
| Hsu, WC | 1 |
| Hsiao, CH | 1 |
| Sherlock, M | 1 |
| Roche, M | 1 |
| Agha, A | 1 |
| Smyth, E | 1 |
| Thompson, CJ | 1 |
| Zanchi, A | 1 |
| Mencarelli, M | 1 |
| Sansoni, A | 1 |
| Rossolini, A | 1 |
| Cellesi, C | 1 |
| Tsang, KW | 1 |
| Rutman, A | 1 |
| Kanthakumar, K | 1 |
| Belcher, J | 1 |
| Lund, V | 1 |
| Roberts, DE | 1 |
| Read, RC | 1 |
| Cole, PJ | 1 |
| Wilson, R | 1 |
| Barriere, SL | 1 |
| Hindler, JA | 1 |
| O'Driscoll, JC | 1 |
| Keene, GS | 1 |
| Weinbren, MJ | 1 |
| Johnson, AP | 1 |
| Palepou, MF | 1 |
| George, RC | 1 |
| Margelli, D | 1 |
| Streit, E | 1 |
| Leahey, AB | 1 |
| Jones, D | 1 |
| Georgiou, M | 1 |
| García, C | 1 |
| Gómez-Lus, R | 1 |
| Escobar, H | 1 |
| Baquero, F | 1 |
| Stumvoll, M | 1 |
| Fritsche, A | 1 |
| Samuel, W | 1 |
| Dryden, M | 1 |
| Sampson, M | 1 |
| Page, A | 1 |
| Shepherd, H | 1 |
| Hung, CC | 1 |
| Hsueh, PR | 1 |
| Chen, YC | 1 |
| Fang, CT | 1 |
| Chang, SC | 1 |
| Luh, KT | 1 |
| Hsieh, WC | 1 |
| Hart, AJ | 1 |
| Thompson, P | 1 |
| Casey, AT | 1 |
| Davies, AP | 1 |
| Stannard, AJ | 1 |
| Pillai, A | 1 |
| Mitchell, JL | 1 |
| Hill, SL | 1 |
| Stockley, RA | 1 |
| Marco, F | 1 |
| García-de-Lomas, J | 1 |
| García-Rey, C | 1 |
| Bouza, E | 1 |
| Aguilar, L | 1 |
| Fernández-Mazarrasa, C | 1 |
| Dawson, SJ | 1 |
| White, LA | 1 |
| Hirata-Dulas, CA | 1 |
| Stein, DJ | 1 |
| Guay, DR | 1 |
| Gruninger, RP | 1 |
| Peterson, PK | 1 |
| Visvanathan, K | 1 |
| Jones, PD | 1 |
| Teigen, K | 1 |
| Lingaas, E | 1 |
| Davies, BI | 2 |
| Maesen, FP | 2 |
| Teengs, JP | 1 |
| Baur, C | 2 |
| Quentin, R | 1 |
| Koubaa, N | 1 |
| Cattier, B | 1 |
| Gavignet, M | 1 |
| Goudeau, A | 1 |
| van den Broek, PJ | 1 |
| Bakker, W | 1 |
| Mattie, H | 1 |
| van Gulpen, C | 1 |
| Kemmerich, B | 1 |
| Borner, K | 1 |
| Pennington, JE | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Klein, SJ | 1 |
| Shalit, I | 1 |
| Stutman, HR | 1 |
| Marks, MI | 1 |
| Chartrand, SA | 1 |
| Hilman, BC | 1 |
2 trials available for ciprofloxacin and Haemophilus Infections
| Article | Year |
|---|---|
A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bronchitis; Ceftriaxone; Ciprofloxacin; Cross Infecti | 1991 |
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
Topics: Adolescent; Adult; Bronchopneumonia; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Femal | 1987 |
41 other studies available for ciprofloxacin and Haemophilus Infections
| Article | Year |
|---|---|
Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Haemophilus I | 2007 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta | 2023 |
Haemophilus Influenzae Endogenous Endophthalmitis in an Immunocompetent Host.
Topics: Adolescent; Anti-Bacterial Agents; Cataract Extraction; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug | 2021 |
Ciprofloxacin resistance in nontypable Haemophilus influenzae clinical isolates.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Ciprofloxacin; Drug Resistance, Bacterial; Female; Haem | 2019 |
The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Deoxyribonuclease I; Edetic Acid; Haemop | 2014 |
Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Ciproflo | 2015 |
Genital carriage of the genus Haemophilus in pregnancy: species distribution and antibiotic susceptibility.
Topics: Adolescent; Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Dru | 2015 |
Infected Abdominal Aortic Aneurysm Attributable to Haemophilus influenzae: Rapid Changes of Imaging Findings.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel Pro | 2015 |
Molecular characterisation of the clonal emergence of high-level ciprofloxacin-monoresistant Haemophilus influenzae in the Region of Southern Denmark.
Topics: Aged; Bacterial Typing Techniques; Ciprofloxacin; Denmark; Drug Resistance, Bacterial; Female; Genes | 2016 |
Treatment of otitis media by transtympanic delivery of antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biomechanical Phenomena; Child; Chinchilla; | 2016 |
In vivo efficacy of sitafloxacin in a new murine model of non-typeable Haemophilus influenzae pneumonia by sterile intratracheal tube.
Topics: Animals; Anti-Bacterial Agents; Bronchioles; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones | 2009 |
[Peritonitis in the course of peritoneal dialisis caused by Haemophilus influenzae with BLNAR phenotype].
Topics: Adolescent; Ampicillin Resistance; Ascitic Fluid; Ciprofloxacin; Haemophilus Infections; Haemophilus | 2009 |
Haemophilus influenza infection complicating a total knee arthroplasty.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arthroplasty, Replacement, Knee; Ciprofloxacin; | 2002 |
"Ciprofloxacin: a warning for clinicians".
Topics: Achilles Tendon; Anti-Infective Agents; Ciprofloxacin; Haemophilus Infections; Haemophilus influenza | 2002 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective | 2003 |
Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Topics: Aza Compounds; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Topoisomerase IV; Fluoroqu | 2004 |
["Actinobacillus and Haemophilus parainfluenzae infective endocarditis: two case reports"].
Topics: Actinobacillus Infections; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Therapy, C | 2004 |
Idiopathic subconjunctival abscess.
Topics: Abscess; Anti-Infective Agents; Ciprofloxacin; Conjunctival Diseases; Diagnosis, Differential; Femal | 2004 |
A case of Haemophilus aphrophilus and Mobiluncus mulieris hepatic abscess.
Topics: Actinomycetales Infections; Ciprofloxacin; Female; Gentamicins; Haemophilus; Haemophilus Infections; | 2005 |
Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti- | 1994 |
Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics.
Topics: Adenoids; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Ciprofloxacin; Dose- | 1993 |
Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease.
Topics: Adult; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus Infections; Haemophil | 1993 |
Haemophilus aphrophilus discitis and vertebral osteomyelitis.
Topics: Abscess; Anti-Infective Agents; Cephalosporin Resistance; Ciprofloxacin; Discitis; Haemophilus; Haem | 1995 |
[Haemophilus aphrophilus as a rare cause of bacterial spondylitis].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Haemophilus; Haemophilus Infections; Humans; Male; Para | 1996 |
Haemophilus influenzae central corneal ulcer associated with cosmetic lens wear.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Co | 1996 |
Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis.
Topics: Adult; Ampicillin Resistance; Anti-Infective Agents; beta-Lactamases; Chloramphenicol Resistance; Ci | 1996 |
Necrotizing fasciitis caused by unencapsulated Haemophilus influenzae.
Topics: Anti-Infective Agents; Bacterial Capsules; Buttocks; Ciprofloxacin; Diabetes Mellitus, Type 1; Diagn | 1997 |
Spinal abscess of Haemophilus paraphrophilus. A case report.
Topics: Abscess; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination | 1997 |
Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis.
Topics: Abscess; Aged; Bacteremia; Cefotaxime; Ciprofloxacin; Epidural Space; Female; Haemophilus; Haemophil | 1997 |
Haemophilus paraphrophilus; a rare cause of intracranial abscess.
Topics: Adult; Brain; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Haemophilus; Haemophilus Inf | 1998 |
A case of Haemophilus parainfluenzae pneumonia.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Blood Sedimentation; C-Reactive Protein; Ciprof | 2000 |
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Haemophilus Infections; Haemophilus influenza | 2001 |
Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin.
Topics: Adult; Cefotaxime; Ciprofloxacin; Endocarditis, Bacterial; Haemophilus Infections; Humans; Male; Mic | 1992 |
Ciprofloxacin treatment of Haemophilus paraphrophilus brain abscess.
Topics: Abscess; Adult; Brain Diseases; Ciprofloxacin; Haemophilus Infections; Humans; Male | 1991 |
In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients.
Topics: Aztreonam; beta-Lactamases; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microb | 1990 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Cipr | 1986 |
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Drug | 1986 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, | 1988 |
The use of ciprofloxacin in the treatment of patients with cystic fibrosis.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Haemophilus | 1987 |
Comparative efficacies of ciprofloxacin, ampicillin and chloramphenicol in treatment of experimental Haemophilus influenzae pneumonia.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Haemophilus Infections; Haemophilus inf | 1987 |
Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Ciprofloxacin; Female; | 1987 |